HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis.

Abstract
There is very little evidence regarding the safety and efficacy of opioids for the control of dyspnoea in the terminal stages of idiopathic pulmonary fibrosis (IPF). We conducted an open case series study of 11 elderly opioid-naive patients referred for management of severe breathlessness before and after their first injection of 2.5 mg diamorphine subcutaneously. Subjective breathlessness, measured by a 100 mm visual analogue scale, fell by a mean of 47 mm in the first 15 min (P < 0.0001) and the mean heart rate fell by 12/min (P = 0.007). There were small non-significant falls in the mean respiratory rate (2/min), systolic blood pressure (6 mmHg) and oxygen saturation (1%). These changes were maintained at 30 min. Follow up treatment with oral morphine remained effective in reducing the symptom of breathlessness and no patient showed signs of respiratory depression. Low dose opioids are effective and safe in the palliative management of IPF in frail elderly patients.
AuthorsStephen Allen, Satru Raut, Jane Woollard, Michael Vassallo
JournalPalliative medicine (Palliat Med) Vol. 19 Issue 2 Pg. 128-30 (Mar 2005) ISSN: 0269-2163 [Print] England
PMID15810751 (Publication Type: Journal Article)
Chemical References
  • Analgesics, Opioid
  • Morphine
Topics
  • Acute Disease
  • Aged
  • Aged, 80 and over
  • Analgesics, Opioid (administration & dosage)
  • Dyspnea (drug therapy)
  • Female
  • Humans
  • Male
  • Morphine (administration & dosage)
  • Pulmonary Fibrosis (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: